Affiliation:
1. First Hospital of Jilin University
2. Qiyang peoples' hospital
Abstract
Abstract
Background
The correlation between low levels of vitamin D and an increased risk of various inflammatory diseases has been well established. However, the specific relationship between vitamin D levels and mortality in individuals suffering from chronic obstructive pulmonary disease (COPD) remains unclear. Therefore, the aim of this investigation was to explore the link between serum 25-hydroxyvitamin D [25(OH)D] concentrations and the probability of mortality from all causes and cardiovascular diseases (CVD) in American adults diagnosed with COPD.
Methods
A total of 1796 adults diagnosed with COPD, who participated in the National Health and Nutrition Examination Survey (2007–2018), were enrolled in this study. Data regarding deaths were obtained through linkage to the National Death Index (NDI) records until December 31, 2019. The association between 25(OH)D concentrations and the risk of mortality was examined both continuously using restricted cubic splines and categorically (< 25.0, 25.0–49.9, 50.0–74.9, and ≥ 75.0 nmol/L) through Cox regression modeling. Competing risk models were employed to explore the relationship between serum 25(OH)D levels and the incidence of CVD-related mortality in individuals diagnosed with COPD. Sensitivity and stratified analyses were conducted to assess the robustness of the findings.
Results
Over the course of the follow-up period, a total of 357 cases of all-cause mortality were observed, of which 85 were attributed to CVD-related causes. After accounting for various confounding factors, the study revealed that lower serum 25(OH)D levels were significantly associated with a heightened risk of all-cause and CVD-related mortality among COPD patients. When compared to individuals in the lowest category, those in the highest category of serum 25(OH)D showed a 52% reduction in all-cause mortality (HR: 0.48, CI [0.24, 0.94]) and a 69% increase in CVD-related mortality (HR: 0.31, CI [0.11, 0.84]). No evidence of a non-linear association between DII levels and all-cause mortality (p-non-linear = 0.1145) was found.
Conclusions
Our research indicates that among COPD patients, those with high serum vitamin D concentrations have a lower risk of all-cause and cardiovascular death compared to those with vitamin D deficiency. This demonstrates a non-linear negative correlation, supporting the long-term beneficial effect of vitamin D on COPD patients.
Publisher
Research Square Platform LLC
Reference48 articles.
1. 1. Collaborators GBDCD. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in;195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (vol 392, pg 1736, 2018). Lancet. 2018;392(10160):2170-.
2. 2. Fazleen A, Wilkinson T. Early COPD: current evidence for diagnosis and management. Therapeutic Advances in Respiratory Disease. 2020;14.
3. 3. Buist AS, McBurnie MA, Vollmer WM. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study (vol 370, pg 741, 2007). Lancet. 2012;380(9844):806-.
4. 4. O'Donnell DE, Elbehairy AF, Berton DC, Domnik NJ, Neder JA, Crrn. Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases. Frontiers in Physiology. 2017;8.
5. 5. Annesi-Maesano I. Air Pollution and Chronic Obstructive Pulmonary Disease Exacerbations: When Prevention Becomes Feasible. American Journal of Respiratory and Critical Care Medicine. 2019;199(5):547-8.